Literature DB >> 3859837

Human X chromosome markers and Duchenne muscular dystrophy.

K E Davies, A Speer, F Herrmann, A W Spiegler, S McGlade, M H Hofker, P Briand, R Hanke, M Schwartz, V Steinbicker.   

Abstract

Two DNA markers, a random DNA fragment 754 and the cDNA sequence encoding the gene for ornithine transcarbamylase (OTC) have been studied in kindreds segregating for Duchenne muscular dystrophy. 754 and OTC are located close physically to the mutation in the region Xp21 below the breakpoints in two Duchenne females. The genetic distance was found to be approximately 10cM between 754 and DMD (two crossovers in 26 meioses) and to be approximately 10cM between OTC and DMD (two crossovers in 26 meioses). Physical data suggest the order DMD-754-OTC. The frequency of recombination compared to physical distance between these markers and DMD suggests that there may be a hot spot of recombination. The relevance of these observations for the isolation of the DMD mutation and clinical use of these probes is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3859837      PMCID: PMC341249          DOI: 10.1093/nar/13.10.3419

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  Localisation of gene for Becker muscular dystrophy.

Authors:  H M Kingston; P S Harper; P L Pearson; K E Davies; R Williamson; D Page
Journal:  Lancet       Date:  1983-11-19       Impact factor: 79.321

2.  A cytological map of the human X chromosome--evidence for non-random recombination.

Authors:  D A Hartley; K E Davies; D Drayna; R L White; R Williamson
Journal:  Nucleic Acids Res       Date:  1984-07-11       Impact factor: 16.971

3.  Genetic mapping of the human X chromosome by using restriction fragment length polymorphisms.

Authors:  D Drayna; K Davies; D Hartley; J L Mandel; G Camerino; R Williamson; R White
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

4.  Construction and characterization of genomic libraries from specific human chromosomes.

Authors:  R Krumlauf; M Jeanpierre; B D Young
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy.

Authors:  P S Harper; T O'Brien; J M Murray; K E Davies; P Pearson; R Williamson
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

6.  Toward a complete linkage map of the human X chromosome: regional assignment of 16 cloned single-copy DNA sequences employing a panel of somatic cell hybrids.

Authors:  P Wieacker; K E Davies; H J Cooke; P L Pearson; R Williamson; S Bhattacharya; J Zimmer; H H Ropers
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

7.  Translocation (X;6) in a female with Duchenne muscular dystrophy: implications for the localisation of the DMD locus.

Authors:  M Zatz; A M Vianna-Morgante; P Campos; A J Diament
Journal:  J Med Genet       Date:  1981-12       Impact factor: 6.318

8.  Clinical use of DNA markers linked to the gene for Duchenne muscular dystrophy.

Authors:  M E Pembrey; K E Davies; R M Winter; R G Elles; R Williamson; T A Fazzone; C Walker
Journal:  Arch Dis Child       Date:  1984-03       Impact factor: 3.791

9.  Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome.

Authors:  H M Kingston; N S Thomas; P L Pearson; M Sarfarazi; P S Harper
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

10.  Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome.

Authors:  C Verellen-Dumoulin; M Freund; R De Meyer; C Laterre; J Frédéric; M W Thompson; V D Markovic; R G Worton
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more
  20 in total

1.  Forensic mass screening using mtDNA.

Authors:  Reinhard Szibor; Ines Plate; Herrmann Schmitter; Holger Wittig; Dieter Krause
Journal:  Int J Legal Med       Date:  2006-04-01       Impact factor: 2.686

Review 2.  Molecular genetics of the human X chromosome.

Authors:  K E Davies
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

3.  RFLP-discordance within the human phenylalanine hydroxylase locus.

Authors:  O Riess; A Michel; W Berger; P Nürnberg; J T Epplen; A Speer; C Coutelle
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

4.  Linkage analysis of X linked retinitis pigmentosa in the Irish population.

Authors:  G J Farrar; M T Geraghty; J M Moloney; D J McConnell; P Humphries
Journal:  J Med Genet       Date:  1988-04       Impact factor: 6.318

Review 5.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

6.  DNA linkage analysis of X-linked retinoschisis.

Authors:  N Dahl; P Goonewardena; J Chotai; M Anvret; U Pettersson
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

7.  Crossovers in two German cystic fibrosis families determine probe order for MET, 7C22 and XV-2c/CS.7.

Authors:  W Berger; J Hein; J Gedschold; I Bauer; A Speer; M Farrall; R Williamson; C Coutelle
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

8.  Non-isotopic analysis of single strand conformation polymorphism (SSCP) in the exon 13 region of the human dystrophin gene.

Authors:  U Lenk; R Hanke; U Kräft; K Grade; I Grunewald; A Speer
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

9.  Structural gene aberrations in mucopolysaccharidosis II (Hunter).

Authors:  M Wehnert; J J Hopwood; W Schröder; F H Herrmann
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

10.  Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.

Authors:  W Schröder; L Petruschka; M Wehnert; M Zschiesche; G Seidlitz; J J Hopwood; F H Herrmann
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.